Press Releases.

Inspire® Upper Airway Stimulation (UAS) therapy Press Releases

Inspire Medical Systems Secures $14.5M in Series C Financing, Completes Implants in its STAR Pivotal Trial, and Announces Publication of Feasibility Study Results
May 11, 2012

Inspire Medical Systems, the leading developer of neurostimulation therapies for the treatment of obstructive sleep apnea (OSA), provided an update today on four important company initiatives:

Read More...

Inspire Medical Systems Reaches Milestones with its Sleep Apnea Therapy
June 9th, 2011

STAR pivotal trial actively recruiting and implanting patients at 9 US sites; Feasibility study data shows therapy may significantly reduce severity of sleep apnea in well selected patients.

Read More...

Inspire Medical Systems Announces FDA approval for Pivotal Clinical Trial
November 30th, 2010

Inspire Device for Obstructive Sleep Apnea will be tested at sites in US and Europe.

Read More...

Inspire Medical Systems Completes First Implant of the Inspire II System to Treat Obstructive Sleep Apnea
February 26th, 2009

Second generation implantable device utilizes electrical stimulation to prevent airway closure during sleep.

Read More...